Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 USD | +13.99% | -16.25% | -54.69% |
05-15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.69% | 97.04M | |
+7.41% | 223B | |
+11.63% | 195B | |
+18.64% | 144B | |
+30.01% | 111B | |
+2.32% | 65.19B | |
+14.03% | 53.02B | |
+2.68% | 50.28B | |
+7.03% | 44.15B | |
+2.48% | 36.45B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Transcript : Akoya Biosciences, Inc., Q4 2022 Earnings Call, Mar 06, 2023